Skip to content

Clinical trials

Phase 2 Pulmonary Disease, Chronic Obstructive trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 2 Country / region: Italy Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20042
20072
20101
20111
20121
20131
20151
20162
20172
20192
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Terminated2
Active, not recruiting1
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca4
GlaxoSmithKline3
Chiesi Farmaceutici S.p.A.2
Novartis2
Campus Bio-Medico University1
Merck Sharp & Dohme LLC1
Mereo BioPharma1
Novartis Pharmaceuticals1
University Hospital of Ferrara1
University of Milan1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive19
Respiration Disorders2
Coronary Artery Disease1
Emphysema1
Herpes Zoster1
Hypertension, Pulmonary1
Inflammation1
Pulmonary Emphysema1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.